Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Int J Drug Policy. 2020 Oct 7;86:102971. doi: 10.1016/j.drugpo.2020.102971

Table 5.

Differences on cannabis outcomes by purchasing patterns

Money Spent # of products # of times used/day Quantity of flower/buds CUDIT Solitary Use Consequences
Model 1
 Intercept 22.98 p<.01 2.21 p<.01 2.22 p<.01 0.52 p<.01 0.21 p=.29 0.38 p<.01 1.43 p<.01
 Total Sources Types# 21.29* p<.01 0.69* p<.01 0.57* p<.01 0.19* p<.01 0.98* p<.01 0.20* p<.01 0.68* p<.01
Model 2
 Family/Friend (ref) 22.12 p<.01 2.35 p<.01 1.85 p<.01 0.55 p<.01 0.69 p<.01 0.39 p<.01 1.85 p<.01
 Medical Cannabis Dispensary 66.59 p<.01 3.74* p<.01 2.87* p<.01 0.96* p<.01 2.03* p<.01 0.68* p<.01 2.45* p<.01
 Recreational Cannabis Retailer 50.34 p<.01 3.04* p<.01 2.30* p<.01 0.72* p=.01 1.48* p<.01 0.69* p<.01 2.37* p<.01
 Stranger/Dealer 49.03 p=.06 2.81 p=.12 2.76* p<.01 0.74 p=.15 2.06* p<.01 0.56* p=.01 3.35* p<.01

Note. Model 1 coefficients are estimates from regression with slopes denoted (#). Model 2 are actual proportions for each group computed from regression coefficients. Significant differences in Model 2 reflect differences with the reference group (i.e., Family/Friend source of cannabis). All significant effects are at p<.05 and denoted (*). Statistical significance (p-value) is also presented for the reference groups (i.e., intercept) to indicate whether the estimate is significantly different from zero.